American Century Companies Inc. Grows Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

American Century Companies Inc. raised its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 143.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,051 shares of the company's stock after acquiring an additional 5,339 shares during the period. American Century Companies Inc. owned approximately 0.06% of U.S. Physical Therapy worth $803,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the company. HighTower Advisors LLC boosted its position in U.S. Physical Therapy by 2.5% during the fourth quarter. HighTower Advisors LLC now owns 4,833 shares of the company's stock valued at $429,000 after purchasing an additional 119 shares in the last quarter. CBIZ Investment Advisory Services LLC grew its holdings in U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after purchasing an additional 122 shares during the last quarter. Albert D Mason Inc. increased its position in U.S. Physical Therapy by 1.3% during the 4th quarter. Albert D Mason Inc. now owns 10,596 shares of the company's stock valued at $940,000 after buying an additional 139 shares in the last quarter. Harbor Capital Advisors Inc. increased its holdings in shares of U.S. Physical Therapy by 1.0% during the fourth quarter. Harbor Capital Advisors Inc. now owns 16,344 shares of the company's stock valued at $1,450,000 after acquiring an additional 156 shares in the last quarter. Finally, Norden Group LLC raised its position in shares of U.S. Physical Therapy by 4.8% in the 4th quarter. Norden Group LLC now owns 5,139 shares of the company's stock valued at $456,000 after purchasing an additional 235 shares during the last quarter.

Remove Ads

Analyst Ratings Changes

A number of brokerages recently issued reports on USPH. JPMorgan Chase & Co. reduced their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. Bank of America upgraded shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and increased their price target for the stock from $100.00 to $115.00 in a report on Monday, December 16th. JMP Securities started coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They set an "outperform" rating and a $113.00 price objective for the company. Barrington Research reduced their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Finally, William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $109.00.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 1.70% of the company's stock.

U.S. Physical Therapy Price Performance

USPH traded down $0.30 on Tuesday, reaching $69.55. 158,100 shares of the company's stock were exchanged, compared to its average volume of 105,833. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $108.14. The stock has a market cap of $1.06 billion, a PE ratio of 73.99, a P/E/G ratio of 3.54 and a beta of 1.38. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The stock's fifty day moving average price is $77.97 and its 200-day moving average price is $85.22.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. Sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 14th were given a $0.45 dividend. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date was Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a yield of 2.59%. U.S. Physical Therapy's payout ratio is presently 97.83%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.